The extraordinary advancements made over the past several years in the clinical management of cancer have ushered in a new era of optimism for those afflicted with many cancer types. However, these advancements have also created a highly complex environment for healthcare providers and diagnostic laboratory personnel. With the range of clinically informative biomarkers, the types of tests to detect these biomarkers, and the resulting clinical implications constantly expanding and becoming more complex, it has become increasingly burdensome for healthcare professionals to keep pace.
This series will efficiently describe emerging and evolving biomarkers in a series of live webcasts that will be structured to provide a consistent framework in which to consider the application of new information on specific biomarkers.
Each live webcast will feature:
After broadcast, each webinar will be posted on the AMPEDTM online Learning Management System as 1. A complete presentation with pre- and post-tests plus available continuing education credit and 2. A series of short learning modules that can be reviewed based on need and interest in the science, laboratory applications, and/or clinical implications of each marker.
Webinar #1: MGMT: Updated Perspectives, Laboratory Considerations, and Clinical Implications
Speaker: Tejus Bale, MD, PhD
Recorded: Tuesday June 30th, 2020
Webinar #2: HRD Score: Updated Perspectives, Laboratory Considerations, and Clinical Implications
Speaker: Melinda Telli, MD
Date: Tuesday July 21st, 2020 at 2:00pm EDT
Webinar #3: METex14: Updated Perspectives, Laboratory Considerations, and Clinical Implications
Speaker: Nikoletta Sidiropoulos, MD
Date: Tuesday September 29th, 2020 at 2:00pm EDT
This webinar series on Emerging and Evolving Biomarkers (EEB) is planned and coordinated by the Emerging and Evolving Biomarkers Content Committee:
Anthony N. Snow, MD, Content Chair
University of Iowa Hospitals and Clinics, Carver College of Medicine
Kurtis D. Davies, PhD
University of Colorado, Anschutz Medical Campus
Lauren L. Ritterhouse, MD, PhD
Massachusetts General Hospital, Harvard Medical School
And supported by the AMP Training & Education Committee (Yassmine Akkari, PhD, Chair)
This program has been supported through an educational grant from Bristol-Myers Squibb.
AMP is pleased to collaborate in the Immunotherapy Collaborative of Oncology Networked Communities, IC-ONC. IC-ONC is a global information network in which multidisciplinary healthcare providers, responsible for treating patients with cancer, are connected via education.
Please be sure to visit www.ic-onc.org to learn more about the collaborative and all it has to offer.